TY  - GEN
AU  - Banfield,Christopher
AU  - Scaramozza,Matthew
AU  - Zhang,Weidong
AU  - Kieras,Elizabeth
AU  - Page,Karen M
AU  - Fensome,Andrew
AU  - Vincent,Michael
AU  - Dowty,Martin E
AU  - Goteti,Kosalaram
AU  - Winkle,Peter J
AU  - Peeva,Elena
TI  - The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis
SN  - 1552-4604
PY  - 2019///0503
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Biological Availability
KW  - Blood Cell Count
KW  - C-Reactive Protein
KW  - analysis
KW  - Double-Blind Method
KW  - Female
KW  - Healthy Volunteers
KW  - Humans
KW  - Janus Kinase 1
KW  - antagonists & inhibitors
KW  - Male
KW  - Middle Aged
KW  - Protein Kinase Inhibitors
KW  - administration & dosage
KW  - Psoriasis
KW  - blood
KW  - Pyrazoles
KW  - Pyrimidines
KW  - TYK2 Kinase
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jcph.1046
ER  -